Huluwa Pharmaceutical Group was founded in 2008, headquartered in Hainan Island with longevity, health island known as Hainan Island, is China's famous pediatric pharmaceutical companies, national high-tech enterprises, pediatric pharmaceutical industry, the fastest growing, research and development of the strength of the strongest, the most potential for development of one of the pharmaceutical companies, is the only one in the country has been selected as the Chinese Society of Traditional Chinese Medicine Pediatrics Branch vice chairman of the units It is the only pharmaceutical company in China that has been selected as the vice-chairman of the Pediatric Branch of the Chinese Society of Traditional Chinese Medicine.
Huluwa Pharmaceutical Group has four standardized production bases which have passed the new GMP certification, namely: Haikou Medicine Valley Production Base, Haikou Bonded Production Base, Guangxi Nanning Production Base and Hebei Chengde Production Base; it has 31 professional production lines for chemical and traditional Chinese medicines, and the production site is fully standardized in accordance with the 5S management mode, and the quality management system is strictly in accordance with the GMP standard. In recent years, the company has invested hundreds of millions of dollars to build the production base in the valley of medicine, has built 6 modernized preparation buildings, 2 intensive office buildings, production equipment, research and development instruments are at the leading level in the country, the company has enabled the efficient OA office system, convenient financial management system, for the company's high-speed development to lay a solid foundation. 2015 Hulanhua Pharmaceutical Group has successfully acquired Nanning City, Weiwei Pharmaceutical Co. Ltd, including all 65 product approvals, sales network, production equipment, original staff, and the subordinate production base of Chinese medicine pre-treatment and extraction in Pingle, Guangxi, etc., and completed the seamless docking of production and sales in November 15.
At present, Huluwa Pharmaceutical Group owns a group of Hulu Shijiazhuang series of products with nearly 300 product specifications, mainly under the brands of Huluwa, Hulu Dad and Hulu Mom, which have covered the therapeutic areas of pediatrics, gynecology, ophthalmology, orthopedics, respiratory medicine, gastroenterology, hepatobiliary, urology, neurology, and infectious diseases. "There are 25 products in the pediatric series, covering the therapeutic areas of cough, cold, fever, diarrhea, spleen, stagnation, zinc, calcium, antiviral, antibiotic, detoxification, anemia, and enuresis, etc.; 6 products in the gynecological series, covering menstruation regulation, facial nourishment, and so on; and 6 products in the gynecological series, covering the therapeutic areas of menstruation regulation, facial nourishment, and so on. There are 6 products in "Gourd Mother" gynecological series, covering the therapeutic fields of menstruation regulation, skin nourishment, anti-inflammation, qi and blood tonic, blood circulation, blood circulation and pain relief, etc.; and there are more than 100 products in "Gourd Father" adult series, which have fully covered all therapeutic fields of common adult diseases.
Huluwa Pharmaceutical Group has two major sales companies--Hainan Huluwa Pharmaceutical Co., Ltd. and Zhejiang Huluwa Pharmaceutical Co., Ltd. with 10 sales regions and 26 regional divisions, and the sales network has covered all the provinces in China, including the townships and rural sales terminals of more than 2,000 counties in more than 300 districts. Rural sales terminals, with more than 800 medical institutions above the second level, more than 3,000 township hospitals, more than 30,000 clinics and health centers, and more than 50,000 chain and single-pharmacy stores in total. After the successful merger and acquisition of Guangxi Weiwei Pharmaceuticals Co., Ltd. in 2015, the company's marketing network is more sound, and the big chain sales channel is merged into the company's marketing network, which effectively supplements the company's existing marketing The integration of large chain sales channels into the company's marketing network has effectively supplemented the company's existing marketing channels, enabling the company to complete the full coverage of the marketing network in the Chinese mainland market! Production and sales volume for 7 consecutive years with an average annual rate of more than 30% rapid growth, becoming a dark horse in China's pharmaceutical industry!
Huluwa Pharmaceutical Group's marketing services have been upgraded comprehensively, not only upgrading and refining the services for dealers, but also making new planning for services for its own professionalism and occupation, and comprehensively upgrading its brand creativity, product creativity, promotion creativity, and management creativity. Every day, there are more than 2,000 HULUWA professional service personnel in the townships of more than 2,000 counties and cities in more than 300 regions across the country to provide health consultation and product after-sales service for patients and sales terminals, from children's pre-pregnancy, pregnancy, childbirth, infancy, early childhood to school-age all the way up to pre-adults, academic education personnel for your customized to provide professional consulting and related services for the hundreds of millions of children and teenagers in China to bring the gospel.
Huluwa Pharmaceutical Group attaches great importance to pharmaceutical research and development and scientific and technological innovation, has a professional research and development institutions - Hainan Huluwa Technology Development Co. At present, there are 69 varieties under research and development, and 37 patented medicines with independent intellectual property rights, including 4 design patents. In order to promote the development of China's national medicine industry, the company has set up a special R&D center for modernization of traditional Chinese medicine, which has strongly promoted the standardization and internationalization of traditional Chinese medicine.